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1. Introduction 
Since the first serendipitous selective coronary angiography was performed by pediatric 
cardiologist Dr. Mason Sones in 1958 during ventriculography and aortography (Sones et 
al., 1959), invasive coronary angiography has become well established as the diagnostic gold 
standard for coronary artery disease.  
Coronary angiography provides definitive information of “luminology” (radiographic 
outline using a contrast agent) of the coronary arteries. It is the standard with which other 
diagnostic modalities are compared. Millions are performed annually worldwide. Whilst the 
risk of coronary angiography of complications is very low in experienced hands the 
procedure is invasive and, requires dedicated infrastructure and expense. There are certain 
specific indications for coronary angiography. The general indication for a coronary 
angiography is to define the coronary artery anatomy. More detailed guidelines for 
coronary angiography date back to 1999 from the American College of Cardiology (Scanlon 
et al., 1999). This of course predated the enormous technological advancement over the past 
decade, the development in computed tomography coronary angiography, the widespread 
adoption of coronary stenting, the improvement afforded by drug eluting stents, and the 
availability of new antiplatelet therapy that enhanced the safety of all coronary 
interventions. 
This chapter examines the appropriate indications for invasive coronary angiography in the 
current era, assesses the role of non invasive CT coronary angiography, and incorporates the 
emerging adjunctive role in the management of patients undergoing percutaneous cardiac 
structural interventions. Case vignettes are included in this chapter to illustrate the 
indications and use of coronary angiography in the current era. 
It must be stressed whilst guidelines do provide recommendations regarding the indications 
for invasive coronary angiography, many more complex clinical and non clinical factors 
exist for each individual patient and the clinician must exercise clinical acumen to proceed 
to perform an invasive diagnostic and/or therapeutic procedure. 
2. Indications for coronary angiography 
Coronary angiography involves the opacification of the lumen in coronary arteries and 
acquisition of this luminogram under fluoroscopy. Consequently the indication for coronary 
angiography is predominantly focused on the diagnosis of any conditions that can lead to 
luminal compromise. This anatomical study defines the origin, course and pattern of 
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epicardial arteries, with a spatial resolution that is still superior to other non-invasive 
imaging modalities. There are however limitations to coronary angiography. Aside from the 
obvious invasive nature and attendant risks, it provides only a projection of the lumen 
outlined by contrast and hence no information on the extent of atheroma contained within 
the vessel wall or the functional significance of the stenosis which can only be inferred. Both 
of these limitations can be overcome by the use of intravascular modalities such as 
intravascular ultrasound, optical coherence tomography and fractional flow reserve 
assessment. When combined with these adjuncts, coronary angiography serves as a 
formidable tool in guiding revascularization strategies, with a body of scientific data that 
has been well validated to provide long term prognostic benefit.  
The guiding principle in determining the indication behind the decision to undertake 
coronary angiography in a given patients is similar to that underpinning the decision to 
undertake any invasive investigations in medicine. The decision to proceed is based on that 
the knowledge gained from the investigation outweighs the perceived risk, that the result 
will benefit the patient, in that it will likely change management and the available treatment 
option will improve symptoms and/or prognosis. The risks and complications of coronary 
angiography are covered elsewhere in this book and this chapter will focus on the 
indications of coronary angiography. Relative and absolute contraindications are also 
covered briefly. 
The indications for coronary angiography have been divided into the follow clinical 
categories: 
1. Coronary artery disease 
1. Stable pattern 
i. suspected coronary artery disease 
ii. known coronary artery disease 
2. Unstable pattern  
i. Acute coronary syndrome with unstable haemodynamics or rhythm  
ii. Unstable angina and Non-ST elevation MI 
iii. ST elevation MI 
iv. Out of hospital cardiac arrest 
3. Special considerations 
i. Congestive cardiac failure 
ii. Preoperative assessment for non cardiac surgery 
iii. The value of non invasive computed tomography coronary angiography 
4. Relative and absolute contraindications 
2. Prelude to structural cardiac disease/valvular heart disease intervention 
3. Case vignettes of the use of coronary angiography in the contemporary era 
3. Coronary artery disease 
Coronary angiography is pivotal in the diagnostic algorithm as the gold standard for the 
confirmation of coronary artery stenosis. A number of well defined clinical scenarios 
often lead to the suspicion of coronary artery disease. This section is separated into 
patients who present in stable pattern, symptomatic or asymptomatic; and patients who 
present in an acute manner highly suggestive of coronary artery disease, i.e. acute 
coronary syndromes. Specifics scenarios, such as the role of coronary angiography in the 
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investigation of congestive cardiac failure, pre-valvular surgery and the emerging role of 
computed tomography coronary angiography will be covered too. 
3.1.1 Coronary artery disease – stable pattern – suspected coronary artery disease 
The assessment of patients with symptoms suggestive of coronary artery disease (CAD) 
depends on three key factors: the clinical assessment of the quality of symptoms, the clinical 
risk profile, and the presence of existing abnormalities on surface electrocardiogram 
suggestive of CAD.  
The ACC/AHA guidelines on exercise testing (Gibbons, 2002) provide classification of 
symptoms as typical, atypical angina and non-anginal chest pain (table 1). It is well known 
symptoms alone have a poor predictive value and differ between males and females 
(Hemingway et al, 2006, 2008). Combined with the underlying clinical risk profile however, 
a more reliable pre-test probability on CAD can be generated (table 2).  
 
Chest pain Definition 
Typical/definite angina Substernal chest pain or equivalent 
 Provoked by exertion or emotional stress 
 Relieved by rest/nitroglycerin 
Atypical/probable 
angina 
Chest pain or discomfort with two characteristics of definite or 
typical angina 
Non-anginal chest pain Chest pain or discomfort that meets one or none of the typical 
angina characteristics 
Table 1. Classification of chest pain 
 
Age Sex Typical/definite 
angina 
Atypical/probable 
angina 
Nonanginal 
chest pain 
Asymptomatic 
<39 Male 
Female 
Intermediate 
Intermediate 
Intermediate 
Very low 
Low 
Very low 
Very low 
Very low 
40-
49 
Male 
Female 
High 
Intermediate 
Intermediate 
Low 
Intermediate 
Very low 
Low 
Very low 
50-
59 
Male 
Female 
High 
Intermediate 
Intermediate 
Intermediate 
Intermediate 
Low 
Low 
Very low 
>60 Male 
Female 
High 
High 
Intermediate 
Intermediate 
Intermediate 
Intermediate 
Low 
Low 
Table 2. Pretest probability of coronary artery disease based on age, sex and symptoms 
(adapted from Gibbons et al, 2002) 
The resting surface electrocardiogram (ECG) is important in the initial evaluation of the 
patient for two reasons. First, it provides a screening tool to assess for remote infarctions 
(Ammar et al 2004; Michael et al, 2007), with changes such as pathological Q waves, and other 
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non-specific ST segment and T wave changes. Second, any such changes may guide the choice 
of the appropriate functional study. The presence of a left bundle branch block, for example, 
essentially renders exercise stress electrocardiography uninterpretable and confounds 
assessment of stress echocardiography or perfusion studies (La Canna et al, 1992). 
Non-invasive tests such as exercise or pharmacological stress studies form an important 
pathway in the diagnostic algorithm. The value of a functional study cannot be 
overemphasized in patients with atypical or noncardiac chest pains. A negative functional 
study, such a negative treadmill test to 12 minutes on the Bruce protocol, provides sufficient 
prognostic information to negate any further investigations (Myers et al 2002; Marshall et al, 
2010). The ischaemic burden as determined from imaging tests also provides pertinent 
guidance as to the appropriateness of revascularization. A substudy (Shaw et al 2008) of the 
COURAGE trial (Boden et al, 2007), which showed no benefit of PCI over optimized medical 
therapy, did show mortality and MI benefit with revascularizing patients with >10% 
ischaemic myocardial burden. A well executed functional study may also assist in  
localizing the appropriate territory for revascularization, especially in the setting of multi-
vessel intermediate lesions.  
Patients with positive stress tests, especially with high risk features (table three), suggestive 
of significant ischaemic burden, should proceed to coronary angiography for risk 
stratification with a view to possible percutaneous or surgical revascularization. Indeed, of 
the indications of coronary angiography outlined in the ACC guideline for stable angina, a 
positive stress test with high risk features carries the highest level of evidence (Level A) 
compared to all other indications (level B to C).  
 
Noninvasive test results predicting high risk for adverse outcome (> 3% annual mortality rate) 
Severe resting left ventricular dysfunction (LVEF <35%) 
High-risk treadmill score (score  -11) 
Severe exercise induced left ventricular dysfunction (exercise LVEF <35%) 
Stress-induced large perfusion defect (particularly if anterior) 
Stress-induced moderate-size multiple perfusion defects 
Large, fixed perfusion defect with left ventricular dilatation or increased lung uptake 
Stress-induced moderate-size perfusion defect with left-ventricular dilatation or increased 
lung uptake 
Echocardiographic wall motion abnormality (involving >2 segments) developing at low 
dose of dobutamine ( 10mg/kg/min) or at a low heart rate (<120bpm) 
Stress echocardiographic evidence of extensive ischaemia 
Table 3. High risk features in noninvasive tests 
In some patients, however, it may be appropriate to consider coronary angiography as the 
initial investigation to confirm coronary artery disease. Patients who are symptomatic 
despite adequate or maximal antianginal therapy should proceed to coronary angiography 
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with a view to revascularization for symptomatic benefit. As outlined in the ESC guideline 
on myocardial revascularization (Wijns et al, 2010), patients deemed to have a high pretest 
probability of coronary disease are advised against (IIIA and IIIB recommendations) non-
invasive tests but to proceed to coronary angiography (IA recommendation). Patients 
intolerant of non-invasive testings, or with left ventricular dysfunction, could be considered 
for coronary angiography. Cardiac transplant patients continue to form an important group 
of the patients in whom coronary angiography is routinely performed for follow up for 
transplant vasculopathy. It continues to be a class II recommendation for patients awaiting 
organ transplant aged 40 years or older.  
3.1.2 Coronary artery disease – stable pattern – known coronary artery disease 
There is no role for surveillance routine coronary angiography in stable asymptomatic patients 
with known CAD, previous coronary interventions or coronary bypass surgery, unless as 
part of a research protocol. Patients who have documented coronary artery disease and 
previous interventions or CABG, who have developed recurred or worsening symptoms, 
coronary angiography is indicated and may be combined with percutaneous 
revascularization. It is reasonable to proceed to coronary angiography directly in these 
patients. Whilst functional non-invasive tests will still provide localizing data for inducible 
ischaemia, intravascular testing modalities such as intravascular ultrasound, optical 
coherence tomography and fractional flow reserve testing allow a robust evidence based 
approach to guide any revascularization (Tonino et al 2009; Pijls et al 2007). 
3.2 Coronary artery disease – unstable pattern 
3.2.1 Acute coronary syndromes – with haemodynamic instability or rhythm 
disturbance  
Patients who presented with acute coronary syndromes with clinical instability (table 4) 
should proceed to urgent angiography with a view to possible revascularization (Hochman 
et al, 2006) either percutaneously or surgically if indicated.  
 
Clinical instability in acute coronary syndromes 
Cardiogenic shock 
haemodynamic instability - severe hypotension on ischaemia 
Recurrent/Persistent ischaemia and/or chest pain 
Instability in cardiac rhythm e.g. major ventricular arrhythmia 
Table 4. Clinical instability in acute coronary syndromes 
3.2.2 Acute coronary syndromes – unstable angina and non ST elevation acute 
coronary syndromes (non STEACS) 
Non STEACS is the most frequent presentation of acute coronary syndromes and carries at 
least as poor an outcome as STEACS (Chan et al 2009, Polonski et al, 2010).  It is 
recommended (ESC and ACC class I recommendation) that patients who presented with 
non STEACS should be treated with an invasive strategy of coronary angiography. This is 
especially for patients with evidence of ischaemia on ECG or biomarkers, the two most 
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powerful predictors of adverse events, as a prelude to definitive treatment for unstable 
coronary culprit lesions. Several meta-analyses including a Cochrane review (Hoenig et al, 
2006; Fox et al, 2010; Mehta et al, 2005) of randomized controlled trials have concluded a 
routine invasive strategy improved ischaemic endpoints - reducing recurrent ischaemia, 
rehospitalisation and revascularization; and a more recent meta-analysis of three RCTs 
(FRISC-II, ICTUS, RITA-3) in 2010 (Fox et al, 2010) showed the benefit of a routine invasive 
strategy in cardiovascular death or non fatal MI was maintained at five years. Whilst the 
meta-analysis was conclusive, one must note the heterogeneity in the trials included. The 
most controversial trial, published in 2005, comparing a routine invasive vs. conservative 
strategy, ICTUS (de Winter et al, 2005), was the only trial to show no difference in the 
ischaemic end points between the two strategies. Five year follow up data from this study 
continued to show no long-term benefit of an early invasive strategy in reducing death or 
MI (Damman et al, 2010). Notably, 54% of the initially conservatively treated patients 
received revascularization within one year. It is likely the ability of the ICTUS trial to 
demonstrate difference in clinical outcomes has been significantly compromised by the cross 
over rate (Cannon, 2004) from medical therapy to invasive treatment.  
As a result of the heterogeneity between trials (inclusion criteria, definitions of MI, intensity 
of pharmacological treatment and frequency of revascularization) and the confounding 
results, this issue of routine invasive vs. conservative treatment strategy continues to spurn 
passionate debate (Bittl & Maron, 2010; Thompson, 2010). The 2011 ACC guidelines 
(Anderson et al, 2011) acknowledge that in selective patients without high-risk features who 
have been stabilized, an initially conservative strategy may not be inappropriate, especially 
those with serious co morbidities or contraindications to angiography and intervention who 
have an elevated risk for clinical events, for example, patients with advanced malignancy 
and a history of contrast allergy who declines invasive procedures. The decision to avoid 
angiography in these patients may be made by considering the clinical evaluation of the 
physician and patient preference. It is those patients enjoying satisfactory quality of life who 
demonstrate the highest clinical risk profile that derive the most benefit and should receive 
an early invasive strategy. 
When an early invasive approach has been decided for a patient, the exact timing to 
invasive coronary angiography is not very well established and subject to ongoing research. 
This of course differs from the management in STEACS where urgent reperfusion is vital. 
Various trials have attempted to answer the question of timing of coronary angiography in 
NSTEACS. The risk of adverse cardiovascular events is time dependant. These events in the 
unstable patient group are more common in the early phase after initial clinical 
presentation. An early invasive treatment may prevent impending reinfarction or ischaemia, 
but the counterargument is that an adequate pre procedural period of pharmacotherapy 
may “prepare” the lesion better to minimize complications such as no reflow. The data is 
not definitive. Small trials (Neumann et al, 2003), non-clinical primary endpoints 
(Montalescot et al, 2009), possibly underpowered studies (Mehta et al, 2009) are all factors 
that make definitive evidence based recommendations difficult.  
Whilst the evidence differs between various trials, it is reasonable the low to intermediate 
risk NSTEACS patients undergo coronary angiography within 72 hours. This is reflected in 
the conservative arm of recent studies in whom a delayed approach is now considered a 
median of 24 hours after the onset of symptoms compared to 72 hours 10 years ago.  Based 
on subgroup analysis on the TIMACS study in which patients with a GRACE score >140 
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benefited most from an early invasive strategy, this group of high risk patients would 
benefit from prompt (<24 hours) coronary angiography. 
 
 Patients Study design Median 
early vs. 
Late 
difference 
(hrs)
Primary 
endpoint 
Results Other findings 
TACTICS 
TIMI 18 
(2001) 
NSTEACS Angiography 
4-48 vs. 
selective 
invasive
22hrs vs. 
79 hrs 
6 month death, 
MI, 
rehospitalization 
for MI
15.9% vs. 
19.4% 
(p=0.025)
ISAR-
COOL 
(2003) 
NSTEACS Angiography 
< 6 hrs vs. > 
72 hrs
2.4 hrs vs. 
86 hrs 
30 day death or 
large MI 
5.9% vs. 
11.6% 
(p=0.04)
TIMACS 
(2009) 
NSTEACS, 
<24 hrs of 
pain 
Angiography 
< 24 hrs vs. 
>36 hrs after 
randomization
14 hrs vs. 
50 hrs 
6 month death, 
MI, stroke 
9.6% vs. 
11.3% 
(p=0.15) 
Refractory 
ischaemia 3.3% 
vs. 1.0% 
(p<0.001) 
ABOARD 
(2009) 
NSTEACS Angiography 
“immediate” 
vs. delayed 
70 min 
vs. 21 hrs
Peak troponin I 
during 
hospitalization 
2.1 vs. 
1.7 
ng/mL 
20 death, MI, 
urgent 
revascularization 
13.7% vs. 10.2% 
p=0.31 
Table 5. Timing of coronary angiography in NSTEACS 
3.2.3 Acute coronary syndromes – ST elevation ACS 
The cornerstone of management in ST elevation ACS is the timely restoration of flow in the 
infarct related artery. The accepted strategies for reperfusion include primary PCI and 
thrombolysis. If available within a timely fashion from an experienced team, urgent 
coronary angiography and primary PCI offers better patient outcomes than thrombolysis in 
STEACS. In addition, primary PCI is recommended in patients with cardiogenic shock or 
contraindication to thrombolysis.  
In patients with failed thrombolysis, or recurrent ischaemia after initially successful 
thrombolysis, urgent coronary angiography should be considered, as shown in a meta-
analysis in 2007 (Wijeysundera et al, 2007). Rescue PCI is associated with significant risk 
reduction in reinfarction and heart failure, as well as a trend towards mortality reduction. In 
the REACT trial (Gerschlick et al, 2005), there was a significant reduction of the primary 
composite end point of death, reinfarction, stroke or severe heart failure at six months for 
rescue PCI, compared to both conservative treatment of repeat thrombolysis. Long term 
data (Carver et al, 2009), median 4.4 years, from this trial reinforced the mortality reduction 
of rescue PCI over both conservative treatment or repeat thrombolysis (RR 0.41, p=0.004; RR 
0.43, p=0.006, respectively). Repeat thrombolysis is contraindicated. It is associated with 
excessive bleeding and no benefit in reperfusion. In patients who presented to a non PCI-
capable centre, if transfer to a PCI-capable centre can be undertaken such that the delay 
between first medical contact and balloon inflation is less than two hours, patient should be 
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transferred to the PCI-capable centre. Established logistics and personnel arrangement must 
be in place for this to take place.  
In patients with successful thrombolysis, the timing of transfer to a PCI-capable facility and 
the timing of angiography have been addressed in several contemporary trials and meta-
analyses. Several recent meta-analyses (Borgia et al, 2010; Desch et al, 2008; Savio et al, 2010) 
which included studies such as CARESS-AMI (Di Mario et al, 2009), TRANSFER-AMI 
(Cantor et al, 2010) and NORDISTEMI (Bøhmer et al, 2009), demonstrated that early transfer 
to a PCI capable facility is associated with a significant reduction in the combined endpoint 
of 30 day mortality, re-infarction, ischaemia. The benefit appears to be driven most by a 
reduction of re-infarction and ischaemia. Current ESC and ACC guidelines recommend this 
pharmacoinvasive strategy, or “drip and ship” strategy, the prompt transfer of 
thrombolyzed patients to a PCI capable hospital within 24 hours.  
The timing of coronary angiography deserves special mention. In stable patients 
successfully thrombolyzed, having been transferred to a PCI capable facility, coronary 
angiography and PCI should be deferred until 3 to 24 hours after thrombolysis. Whilst 
immediate coronary angiography appears attractive a proposition, evidence from 
“facilitated PCI” suggests otherwise. Facilitated PCI is  a strategy of immediate angiography 
and PCI after pharmacotherapy such as upstream full or half dose thrombolytic therapy, 
with or without glycoprotein IIb/IIIa inhibitor. Several trials have addressed this question. 
ASSENT-4 (ASSENT-4 investigators, 2006), assessing tenecteplase then PCI compared to 
primary PCI, showed increased rates of ischaemic and bleeding complications with 
facilitated PCI, and FINESSE (Ellis et al, 2008, reduced reteplace and abciximab then PCI vs. 
abciximab then PCI vs. PCI) showed no difference in the mortality, ventricular function or 
cardiogenic shock but excess bleeding. A meta-analysis (Keeley et al, 2006) of 18 trials over 3 
decades showed no benefit of facilitated PCI over primary PCI. There is currently no data to 
recommend the use of “facilitated” PCI. Pharmacoinvasive strategy is encouraged but 
facilitated PCI is not. 
Coronary angiography should be performed prior to definitive surgical treatment for 
mechanical complications of any myocardial infarction (e.g. ventricular septal defect, acute 
mitral regurgitation or ventricular aneurysm). There are some situation however where the 
delays associated with angiography may outweigh the benefits of defining the coronary 
anatomy. For example angiography should not delay emergent surgical treatment of VSD 
and shock or aortic dissection. 
3.2.4 Out of hospital cardiac arrest (OOHCA) 
Patients who have survived an out of hospital cardiac arrest with return of spontaneous 
circulation (ROSC) may or may not present with diagnostic ischaemic ECG changes. In 
patients with definitive changes such as ST elevation, they should be treated as outlined 
above with an immediate invasive strategy. In haemodynamically and rhythmically stable 
patients after cardiac arrest, the appropriate timing (immediate vs. deferred) of coronary 
angiography is the subject of particular interest. Up to 80% of OOHCA patients have had an 
acute coronary syndrome as the precipitant (Pell et al, 2003) and ECG changes are not 
necessarily predictive (Aurore et al, 2011). Given this finding, it was not surprising some 
studies (Dumas et al, 2010; Reynolds et al, 2009; Spaulding et al, 1997; Sunde et al, 2007; Stub 
et al 2010) have shown an improved outcome, including cardiac ejection fraction,  
 
www.intechopen.com
 Indications for Coronary Angiography 
 
41 
 
 Patients Study design Primary 
endpoints 
Results Hrs to PCI 
in transfer 
group 
Other 
findings 
CARESS-in-
AMI (2008)  
75 y.o. or 
younger 
STEACS, ½ 
reteplace 
with 
abciximab, 
heparin, 
aspirin 
within 12 
hours of 
pain 
Immediate 
transfer for 
angiography 
±PCI vs. 
standard 
treatment 
(with transfer 
for rescue if 
needed) 
30 day 
death, 
reinfarction, 
refractory 
ischaemia 
RR 0.40 
(p=0.004)
<3  
(median 2.2) 
 
TRANSFER-
AMI (2009)  
STEACS, 
tenecteplase 
within 12 
hours of 
pain 
Immediate 
transfer for 
angiography± 
PCI within 6 
hours vs. 
standard-
treatment 
(deferred > 
24 hrs) 
30 day 
death, 
reinfarction, 
recurrent 
ischaemia, 
new CCF, 
cardiogenic 
shock 
RR 0.64 
(p=0.004)
<6  
(median 3.9) 
 
NORDISTEMI 
(2010) 
75 y.o. or 
younger, 
STEACS, 
teneteplase
<6 hr of 
pain, 
tenecteplase
Immediate 
angiography 
±PCI vs. 
Deferred  
12 month 
death, 
reinfarction, 
stroke, new 
ischaemia 
RR 0.72 
(NS) 
As soon as 
possible 
(median 2.7) 
30 day 
death, 
reinfarction, 
stroke or 
new 
ischaemia 
(RR 0.49 
p=0.03) 
Table 6. Timing of transfer of STEACS patients to a PCI capable facility 
neurological recovery and survival, with this strategy. The largest study of this patient 
group is the PROCAT registry (Dumas et al, 2010) from Paris suggested that immediate 
angiography and successful PCI improved survival (odds ratio 2.06, p=0.013). Given the 
evidence leading centers have adoped a strategy of immediate coronary angiography and 
revascularisation as indicated after an OOHCA with ROSC. Indeed, this is the 
recommendation endorsed by the International Liaison Committee on Resuscitation 
(ILCOR, 2010) but the level of evidence is relatively low. Coma or significant neurological 
compromise are common in this patient group and these should not preclude consideration 
of angiography with full neurological recovery in initially comatose STEACS patients found 
in various registries (Garot et al, 2007; Hosmane et al, 2009). Further, the induction of 
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hypothermia (Bernard et al, 2002; Wolfrum et al, 2008) should be incorporated as part of the 
treatment strategy for those undergoing immediate angiography.  
3.3 Special considerations 
3.3.1 Congestive cardiac failure 
Invasive coronary angiography is useful in the investigation of left ventricular systolic 
dysfunction for an ischemic aetiology, especially in the presence of suggestive features such 
as angina, remote history of severe angina or even silent infarction, ischaemia on surface 
electrocardiogram, or regional wall motion abnormalities on cardiac imaging. Since the 1999 
ACC guideline, the advance of non-invasive computed tomography coronary angiography 
(Andreini et al, 2009), with its high sensitivity and negative predictive value, may justify its 
use for this particular indication rather than invasive coronary angiography. The negative 
predictive value of a normal scan has been shown to approach 100%.  
3.3.2 Preoperative assessment for noncardiac surgery 
The premise of preoperative cardiac, in particular coronary, assessment for noncardiac 
surgery is to prevent peri operative cardiac adverse events and mortality. Surgery places 
significant physiological stresses that may cause cardiac ischaemia from stenosed epicardial 
arteries as well as inflammation and activation of the coagulation cascade possibly 
precipitating acute coronary syndromes.  
As a general rule, the patient should be managed as would be in a non-surgical setting and 
testing of any type should only be undertaken if it is likely to change peri operative 
management. As such, in any emergency life saving operations, it is accepted any cardiac 
investigations should not be performed. 
Coronary angiography has a limited role in the routine management of patients planned for 
non-cardiac surgery. A comprehensive discussion on the preoperative assessment of 
noncardiac surgery is beyond the scope of this chapter but the key determinants are: patient 
symptoms and clinical risk profile, surgical risk estimate (table 7) (Boersma et al, 2005), and 
the patient’s functional capacity.  
 
Surgical risk estimate (adapted from Boersma et al, 2005) – risk of MI and cardiac death at 
30 days 
Low risk <1% Intermediate risk 1-5% High risk >5% 
Breast Abdominal Aortic and major 
vascular surgery 
Dental Carotid Peripheral vascular 
surgery 
Endocrine Peripheral arterial angioplasty  
Eye Endovascular aneurysm repair  
Reconstructive Head and neck surgery  
Orthopaedic – minor e.g. 
knee 
Neurological/major 
orthopaedic 
 
Urologic – minor  Pulmonary/renal/liver 
transplant 
 
 Urologic – major   
Table 7. Risk of adverse cardiac events in different surgical scenarios 
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Patients who have stable angina or are asymptomatic can generally proceed with surgery. 
Patients who have worsening symptoms of ischaemia probably deserve further assessment, 
namely in the form of functional studies, prior to elective surgery. The same indications for 
coronary angiography and/or intervention should apply here as would be in the non-
surgical setting. The cardiac risks of the particular operation should be assessed. It is a class 
I recommendation (Poldermans et al, 2009) that pre-operative coronary angiography be 
performed in acute coronary syndromes as well as in patients with angina refractory to 
medical therapy. Pre-operative angiography is not recommended in cardiac-stable patients 
undergoing low-risk and even intermediate risk surgery. 
Evidence of improved outcome with revascularization prior to surgery however is lacking. 
There is little data pertaining to the benefit of revascularization in patients undergoing non 
cardiac vascular surgery, a subset of surgical patients known for high cardiac co-morbidity. 
One study (McFalls et al, 2004 - Coronary Artery Revascularization Prophylaxis CARP 
study) on stable CAD patients with preserved LV failed to demonstrate improved outcome 
with prophylactic revascularization compared to optimized medical therapy. Another study 
(Poldermans et al, 2007 - DECREASE-V pilot study), assessed the same concept on complex 
CAD with impaired LV systolic function, and reached the same conclusion. This was despite 
75% of these cases having three vessel or left main coronary artery disease. On the currently 
limited available data, prophylactic revascularization cannot be recommended.  
3.3.3 Non invasive computed tomography coronary angiography (CTCA) 
Over the past decade the technological advances in CTCA have meant that the technology is 
emerging as an important investigation in a range of clinical scenarios. Aside from its non-
invasive nature, CTCA provides information about both vessel lumen and important 
information on the composition of plaque and the vessel wall as well as other cardiac 
structures. However, it is important to note the spatial and temporal resolutions remain 
inferior to invasive coronary angiography with the current technology. Various multicentre 
studies (Budoff et al, 2008; Miller et al, 2008; Mowatt et al, 2008) on 64 slice CTCA have been 
published and confirmed its inferiority to invasive coronary angiography particularly in its 
specificity and the limitation on small vessel definition (table 8). The evidence for its clinical 
application continues to evolve.  
 
Study 
author 
Sensitivity 
per vessel 
Specificity 
per vessel 
Sensitivity 
per patient 
Specificity 
per 
patient 
Negative 
predictive 
value  
(per atient) 
Positive 
predictive 
value  
(per patient) 
Budoff et al 
2008 
84% 90% 95% 83% 99% 64% 
Meijboom 
et al 2008 
95% 77% 99% 64% 97% 86% 
Miller et al 
2008 
75% 93% 85% 90% 83% 91% 
Table 8. Meta-analyses of accuracy 64 slice CTCA compared to coronary angiography 
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Guidelines on the appropriateness of CTCA (Taylor et al, 2010) published in 2010 attempted 
to address the use of this rapidly evolving technology. The indications chosen mirrored that 
of invasive coronary angiography. In view of its high sensitivity, CTCA is particularly 
suited to low to intermediate risk patients in the setting of stable symptomatic patients, low 
risk acute coronary syndromes and heart failure patients. Patients with normal CTCA 
findings convey a very low risk of future cardiac events and cardiac mortality (Hulten et al, 
2011). Patients at high risk of coronary artery disease are advised against CTCA as this 
represents hindrance to timely diagnosis and management of CAD with the additional risk 
of contrast and radiation. It has no role in the preoperative assessment of non-cardiac 
surgery. It is deemed appropriate in the assessment of graft patency for symptomatic 
patients with previous CABG. To reflect the emerging role of left main stenting, CTCA has 
been deemed appropriate as a means for routine follow up screening of left main stent(s) in 
asymptomatic patients.  
Unless the limitations of CTCA can be sufficiently improved upon, it is likely CTCA will 
continue to be utilized in a complementary role to invasive coronary angiography in the 
assessment of CAD. Of course the major advantage of angiography remains the ability to 
proceed on to coronary intervention as part of the imaging procedure. 
3.4 Relative and absolute contraindications 
The only absolute contraindication is if a patient refuses the test fully understanding the risk 
and benefit of his/her decision, refuses any treatment for CAD regardless of the result of the 
coronary angiography, or if other medical co-morbidities rendering imaging of the 
coronaries and revascularization inappropriate or impossible. Subjecting the patient to even 
the small risks of a coronary angiogram with no foreseeable gain cannot be justified. 
Relative contraindications include situations which increase the likelihood of complications, 
e.g. bleeding diathesis, coagulopathy (iatrogenic i.e. warfarin or pathological), renal 
impairment, anaemia, contrast allergy, active infection and aortic valve vegetation. If these 
relative contraindications are reversible the patient should be appropriately prepared and 
coronary angiography deferred. 
4. Valvular heart disease and structural heart disease intervention 
The assessment of the coronary anatomy prior to cardiac valvular surgery is routine 
although not necessarily evidence driven. Whilst surgery for valvular heart disease has been 
performed for many years, percutaneous intervention for structural or valvular heart 
disease has been generating significant interest over the recent years. Transcatheter aortic 
valve implants (TAVI) have already demonstrated significant mortality benefit in patients 
deemed unsuitable for surgery compared to medical therapy, in the first RCT on TAVI 
(PARTNERS trial) (Leon et al, 2010). Several investigational percutaneous treatment options 
also exist for mitral regurgitation. Percutaneous coronary revascularization has been a 
prerequisite for the TAVI procedures and as such all patients underwent coronary 
angiography. The incidence of coronary disease in this patient group is high, up to 70% the 
PARTNERS trial. Coronary angiography is a pivotal part in the assessment for TAVI 
suitability. The increasing percutaneous treatment options will likely generate in the future 
specific college endorsed guideline to incorporate the role of coronary angiography in pre 
structural heart intervention.. 
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4.1 Pre valvular surgery 
It is routine to perform coronary angiography prior to valve surgery although there is no 
evidence to guide such practice (Bonow et al, 2006; Vahanian et al, 2007). This is especially 
logical in older patients with cardiac risk factors, or suggestion of CAD from symptoms, 
ECG, cardiac imaging or non-invasive function studies. The indication is less clear in 
younger patients, and special caution must be exercised in aortic valve surgery for infective 
endocarditis given the risk for vegetation embolization. No definitive data are available to 
define the clinical benefit of revascularization in the setting of corrective valve surgery. 
Whilst it is reasonable to expect benefit in prognostic disease, the same generalization may 
not apply to single vessel non prognostic lesions which would otherwise not necessarily be 
revascularized in a non-surgical setting. The role of CTCA is yet to be defined but its 
application here may reasonably mimic that outlined previously, in a low to intermediate 
risk group of patients undergoing valvular surgery (Meijboom et al, 2006). 
4.1.1 Pre percutaneous valve implant 
This is a developing area in which the role of coronary angiography appears crucial. 
Coronary angiography and if necessary percutaneous revascularization were a requisite for 
all TAVI trials so as to allow for direct comparison with the CABG + AVR subgroup. It 
seems nonetheless reasonable for this group of high risk patients, often with symptoms 
indistinguishable from ischaemia, to undergo coronary angiography. In addition, the left 
heart catheterization is pivotal for necessary measurement of aortic dimensions, angulation, 
coronary ostia position and origin, and assessment of vascular access. It should be noted the 
indication of revascularization in patients undergoing TAVI stems from its equivalent in 
surgical treatment, the exact timing and completeness of revascularization are yet to be 
defined. 
The more difficult question relates to the need for coronary angiography in patients who 
may not otherwise meet the indications for coronary angiography, e.g. pulmonary valve 
implant in a young congenital heart disease patient, mitral valve clip in severe functional 
mitral regurgitation. These patients are managed the patient in a similar fashion to the 
conventional indications for coronary angiography.  
4.1.2 Other structural cardiac interventions 
There is limited evidence to support routine coronary angiography in structural cardiac 
interventions such as patent foramen ovale and atrial septal defect closure, coarctation 
stenting, patent ductus arteriosus interventions. It is often performed however based on the 
individual patient’s clinical risk profile. The discovery of prognostically significant coronary 
artery disease not amenable to percutaneous coronary interventions may sway treatment 
towards a complete surgical treatment option. Coronary angiography does not increase the 
invasive nature of these procedures and add little incremental risk. 
5. Case vignettes of the use of coronary angiography in the contemporary 
era 
Case One – atrial septal defect with multi-vessel coronary artery disease 
A 73 year old female presented with NYHA (New York Heart Association) class II 
exertional dyspnoea. Her cardiac risk factors included hypertension and hyperlipidaemia. A 
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transthoracic echocardiogram demonstrated two small secundum atrial septal defects 
(ASD), with moderate right ventricular dilatation and normal systolic function. 
Percutaneous ASD closure was attempted. Coronary angiography was performed, 
especially given the uncharacteristically late presentation of her ASD, as well as her cardiac 
risk factors. This demonstrated prognostically significant triple vessel disease (Figure 1a, 1b, 
2c), with an osital 90% left circumflex artery stenosis, 90% mid left anterior descending 
artery bifurcation stenosis and a 90% distal right coronary artery stenosis. Given the 
unfavourable percutaneous prospect for the coronary lesions, she was referred for surgical 
complete revascularization and ASD closure. She was discharged uneventfully one week 
after surgery. Coronary angiography should be considered prior to structural cardiac 
interventions in patients with cardiac risk factors and may alter management. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1a. Left anterior artery stenoses 
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Fig. 1b. Ostial left circumflex stenosis 
 
 
Fig. 1c. Posterolateral branch stenosis 
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Case Two – post TAVI angiogram 
An 84 year old male represented with angina two years after a successful transcatheter 
aortic valve implant (TAVI) with a bioprosthetic CoreValve®. His NYHA symptomatology 
improved from Class IV to Class I. His coronary angiogram and graft study prior to his 
TAVI showed patent grafts (LIMA-LADD1-LAD; SVG-OM1; SVG-PDA) but severe native 
disease including a severely diseased grafted PDA with no prospect for surgical or 
percutaneous revascularization. A coronary angiogram and graft study was performed 
through his CoreValve® to assess if his underlying disease had progressed (Figure 2a).  
 
 
 
 
 
 
 
 
 
 
Fig. 2a. Angiography with a 5 French Judkins Left 5 catheter through a CoreValve ® 
bioprosthesis 
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This demonstrated patent grafts as previously noted but progression in his PDA disease 
(Figure 2b). Percutaneous, or surgical, treatment remained an unfavourable prospect and he 
was successfully treated with intensified medical therapy with CCS (Canadian 
Cardiovascular Society) I angina. Coronary angiography can be safely performed through 
CoreValve struts but care must be exercised with the choice and manipulation of catheters. 
 
 
Fig. 2b. Severe native posterior descending artery disease not amenable to percutaneous 
treatment 
Case Three – percutaneous treatment of left main stenosis and aortic stenosis  
A 76 year old male with severe aortic stenosis was referred for possible percutaneous 
treatment due to his high surgical risk. Assessment for TAVI entailed a coronary angiogram, 
aortogram and an iliofemoral angiogram (Figure 3a). Coronary angiography revealed a 
significant left main stenosis (Figure 3b) which on intravascular ultrasound measured 5.8 
mm2. A multidisciplinary heart team assessed the data and concluded surgical treatment to 
be prohibitively high risk. The patient then underwent left main stenting with a drug eluting 
stent under IVUS guidance. Satisfactory stent expansion was attained with a final diameter 
of 4.5mm (Figure 3c). The patient then proceeded to a successful TAVI (CoreValve®) 
implant and continued to enjoy excellent symptom relief at six months.  
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Coronary angiography, and arterial (aortic, iliac, and femoral) assessment, form an integral 
part of TAVI assessment. Elderly patients with severe aortic stenosis often have severe co-
existing coronary artery disease as well as peripheral vascular disease as demonstrated by 
this case. Optimizations of the coronary status, as well as an appreciation of the peripheral 
vasculature, are absolutely paramount to a successful TAVI implant and to avoid vascular 
complications. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3a. Tortuous aorta and iliac arteries, important information for TAVI transfemoral 
access. 
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Fig. 3b. Mid shaft left main stenosis 
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Fig. 3c. Drug eluting stent deployment in left main guided by IVUS 
Case Four – anomalous coronary artery 
A 63 year old male underwent coronary angiography after being successfully thrombolyzed 
for an inferior STEACS, 24 hours after his original pain onset. Coronary angiography via his 
right femoral artery showed a normal left coronary system but the origin of the right 
coronary artery (RCA) was not in the usual sinus. An Amplatz left catheter 2 (AL2) 
eventually revealed (Figure 4a) an anomalous RCA from the opposite sinus (ACAOS). A 
95% stenosis in the mid RCA was found and after trying various catheters, an EBU (extra 
back up) 3.5 guiding catheter (Medtronic ®), traditionally a left coronary catheter, made it 
possible for a successful intervention and the placement of a coronary stent (Figure 4b and 
4c). A CTCA (Figure 4d) was performed to ascertain the course of the RCA and confirmed 
ACAOS. Percutaneous coronary intervention in anomalous coronary arteries required 
innovative use of guiding catheters. 
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Fig. 4a. Right coronary artery injection with a 5Fr AL2 catheter showing an anomalous right 
coronary origin with impossible selective engagement 
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Fig. 4b. A 6Fr EBU catheter used to engage the anomalous origin. Traditional right coronary 
catheters would not have been useful. 
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Fig. 4c. Successful placement of a drug eluting stent in the mid RCA with no residual 
stenosis. 
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Fig. 4d. CTCA 3D reconstruction shows the origin and course of the anomalous right 
coronary artery clearly and defines its ante-aortic course. 
Case Five – CTCA in graft assessment 
A 69 year old male developed atypical chest pain 12 months after his coronary bypass graft 
(LIMA-LAD; RA-ramus; SVG-OM1). During the initial angiographic assessment he 
underwent IVUS of his left main and left anterior descending artery indeterminate lesions. 
IVUS showed his LM to be 5.44mm2 and LAD 3.96mm2. These were thought be suggest 
significant stenoses. To investigate his current atypical chest pain an MPS (Figure 5a) was 
performed which showed no inducible ischaemia or symptoms. A CTCA (Figure 5b) was 
performed which however suggested possible occluded LIMA graft. A coronary angiogram 
and graft study (Figure 5c and 5d) confirmed this finding that the LIMA graft had become 
atretic and normal coronary flow seen in the LAD. His other grafts were patent as was 
shown on the CTCA. This case demonstrated the value of CTCA in identifying graft patency 
and position, often facilitating the location of the graft anastomosis at the aorta. The atypical 
symptoms, patent coronary arteries and grafts, correlated well with his negative functional 
study. The LIMA-LAD graft probably underwent atresia as a result of no physiological 
implication to his intermediate LM and LAD lesions even though the diameters measured 
fulfilled conventional criteria for significant lesions.  
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Fig. 5a. Myoperfusion study with no significant inducible ischaemia. 
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Fig. 5b. Position of two aortic grafts demonstrated clearly on CTCA. No LIMA flow 
demonstrated. 
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Fig. 5c. LAD artery with no obvious proximal stenosis and normal coronary flow.  
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Fig. 5d. Small atretic LIMA. 
Case Six – balanced ischaemia on MPS in a high risk patient 
A 67 year old male with 20 years of diabetes mellitus II and 40 pack year history of smoking 
presented with six months of worsening exertional dyspnoea and chest pain. A 
myoperfusion study performed at a satisfactory level of workload demonstrated a small 
area of mildly reversible ischaemia in the inferolateral area. Given the abnormal findings, 
the patient proceeded to coronary angiography. This revealed severe distal left main artery 
stenosis, with a subtotally occluded left circumflex and a proximal severe RCA stenosis. Left 
ventricular function was normal. The extent and severity of disease was of prognostic 
significance. The patient underwent uneventful coronary bypass grafting and was 
discharged from the hospital one week after. This patient exhibited a high pretest 
probability based on the clinical profile. Whilst the myoperfusion study was suggestive, it 
underestimated the extent of disease likely due to the balanced ischaemia from the RCA and 
LM stenoses. Complex distal left main stenosis, especially bifurcation stenosis, is best 
treated with surgical revascularization. 
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Fig. 6a. Distal left main eccentric stenosis and ostial circumflex stenosis. 
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Fig. 6b. Proximal right coronary artery stenosis 
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6. Conclusion 
Coronary angiography remains the most accurate diagnostic modality for coronary artery 
disease. It provides a definitive assessment of coronary artery lumen and provides an 
avenue to percutaneous intervention. It is pivotal in the treatment on unstable or acute 
coronary syndromes and life saving in cardiogenic shock and STEACSs. Indications for 
invasive coronary angiography have changed incrementally over the decade since 
ACC/AHA guidelines on the topic were published. The advent of noninvasive CTCA has 
changed the landscape for the diagnosis of CAD but CTCAs seem destined only for the low 
to intermediate risk patients. Coronary angiography also serves a pivotal role in the 
burgeoning field of percutaneous structural cardiac interventions, especially percutaneous 
valve implants. 
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